Matt Crusan has been appointed director of DEA Compliance and Services at QPharma. Mr. Crusan has served as a diversion investigator with the Drug Enforcement Administration (DEA), and brings extensive knowledge of DEA regulatory policy to QPharma’s newly established DEA compliance practice.   Mr. Crusan joins the company from the Pharma Compliance Group, where he served as director of regulatory affairs providing DEA compliance consulting services to manufacturers, distributors, hospitals, and ...